Verition Fund Management’s Medtronic MDT Stock Holding History

Verition Fund Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,300	Closed	-$2.05M	–	3055
2025 Q4	$2.05M	Sell	21,300 -38,600	-64%	-$3.75M	0.01%	1598
2025 Q3	$5.7M	Sell	59,900 -6,600	-10%	-$607K	0.02%	1011
2025 Q2	$5.8M	Buy	66,500 +33,800	+103%	+$2.87M	0.03%	966
2025 Q1	$2.94M	Sell	32,700 -4,400	-12%	-$394K	0.01%	1282
2024 Q4	$2.96M	Sell	37,100 -19,100	-34%	-$1.65M	0.01%	1281
2024 Q3	$5.06M	Buy	56,200 +100	+0.2%	+$8.41K	0.03%	847
2024 Q2	$4.42M	Hold	56,100	–	–	0.02%	796
2024 Q1	$4.89M	Buy	56,100 +30,500	+119%	+$2.6M	0.03%	693
2023 Q4	$2.11M	Buy	25,600 +6,000	+31%	+$457K	0.02%	807
2023 Q3	$1.54M	Buy	+19,600	New	+$1.64M	0.02%	894
2023 Q1	–	Sell	-4,100	Closed	-$319K	–	2402
2022 Q4	$319K	Hold	4,100	–	–	0.01%	1472
2022 Q3	$331K	Buy	+4,100	New	+$368K	﹤0.01%	2151
2022 Q2	–	Sell	-7,300	Closed	-$810K	–	2790
2022 Q1	$810K	Buy	+7,300	New	+$771K	0.01%	1610

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's MDT Position: Q1 2026 in Review

Verition Fund Management reduced its Medtronic (MDT) stake by 70% in Q1 2026, selling an estimated $2.56M and leaving 11,186 shares worth $969K. The position accounts for 0.01% of the portfolio, ranked #1317.

Verition Fund Management first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $20.3M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Verition Fund Management held 11,186 shares of Medtronic worth $969K as of Q1 2026.
Verition Fund Management sold 26,714 Medtronic shares in Q1 2026, an estimated $2.56M.
Medtronic made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1317 holding.
Verition Fund Management first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
Verition Fund Management's Medtronic position peaked at $20.3M in Q2 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.